Cardio Metabolic Health Congress – Official Blog

Myocarditis Rates Up in Vaccinated Male Adolescents

The U.S. Centers for Disease Control and Prevention (CDC) and other health agencies are investigating a potential link between the COVID-19 vaccine and myocarditis. The condition has been reported at higher-than-usual rates in 12- to 39-year-old males within one week of receiving the second dose of the Pfizer or Moderna mRNA vaccine.

The U.S. Vaccine Adverse Event Reporting System (VAERS) vaccine safety monitoring system has reported an uptick in the number of patients experiencing heart inflammation, or myocarditis, after receiving mRNA COVID-19 vaccines. As of May 31, 2021, there were 475 reports of myocarditis among the recently vaccinated, primarily young men age 16 to 24, according VAERS data. Of the 475 cases, 226 met the CDC’s definition of a “working case” and will be investigated further through patient medical records.

Read more

International NASH Day: New Antibodies Discovered Play Significant Role in NAFLD

June 10th, 2021 celebrates International NASH Day which is part of an ongoing effort supported by CMHC partner, the Global Liver Institute to spread awareness of nonalcoholic steatohepatitis (NASH), the advanced form of nonalcoholic fatty liver disease (NAFLD), as well as actions to address the condition. Currently, the global burden of NAFLD is estimated at a worldwide prevalence of 11%, representing nearly 900 million cases, and has demonstrated a 33% increase over the course of the past 30 years.

Although many patients may experience buildup of fat in the liver without symptoms or health repercussions, in some cases excess fat contributes to inflammation and damage to liver cells even causing cirrhosis. Without appropriate treatment or management, such cases can lead to the development of NAFLD and consequently, to nonalcoholic steatohepatitis. As this condition is an advanced form of disease, it is increasingly important to pinpoint intervention targets and develop effective treatment methods to halt its progression.

Read more